A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-09-29) →
What happened
Iste updated a previously disclosed supply contract with Geumgang ENT Co., Ltd., now worth US$15.2M, about 72.93% of its recent annual revenue, running through Jan 2028.
For context, this single contract equals about 72.93% of the company's most recent annual revenue.
| Counterparty | Geumgang ENT Co., Ltd. |
|---|---|
| Contract value | US$15.2M |
| vs. recent revenue | 72.93% |
| Through | Jan 2028 (from Apr 2026) |
| Filed | 2026-06-26, [Amended] Supply contract signed |
| Source | DART rcept 20260626900710 → open original filing |
Versions of this filing
- 2026-04-22Original
- 2026-06-26Amendment 1 (this page)
- 2026-09-29Amendment 2
Source: DART. Information only, not investment advice.